Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Stephan

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|February 21, 2009
Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffoldFrederick Cohen, Bruno Alicke, Linda O Elliott, et al.
Scientific Reports|September 5, 2018
Gene expression profiling during hibernation in the European hamsterCélia Gautier, Béatrice Bothorel, Dominique Ciocca, et al.
Bioconjugate Chemistry|July 22, 2008
Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determinationJean-Philippe Stephan, Pamela Chan, Chien Lee, et al.
The Journal of Biological Chemistry|September 6, 2015
Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling PathwaySophie Trefely, Poh-Sim Khoo, James R Krycer, et al.
Cancer Research|November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancerMark L McCleland, Adam S Adler, Yonglei Shang, et al.
Endocrinology|February 21, 2004
Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetesLing Fu, Linu M John, Sean H Adams, et al.
The Journal of Clinical Investigation|April 22, 2009
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in miceJing Qing, Xiangnan Du, Yongmei Chen, et al.
Blood|March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphomaAndrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Genes & Development|May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthAdam S Adler, Mark L McCleland, Sharon Yee, et al.
Cancer Cell|October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodiesGabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|February 21, 2009
Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffoldFrederick Cohen, Bruno Alicke, Linda O Elliott, et al.
Scientific Reports|September 5, 2018
Gene expression profiling during hibernation in the European hamsterCélia Gautier, Béatrice Bothorel, Dominique Ciocca, et al.
Bioconjugate Chemistry|July 22, 2008
Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determinationJean-Philippe Stephan, Pamela Chan, Chien Lee, et al.
The Journal of Biological Chemistry|September 6, 2015
Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling PathwaySophie Trefely, Poh-Sim Khoo, James R Krycer, et al.
Cancer Research|November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancerMark L McCleland, Adam S Adler, Yonglei Shang, et al.
Endocrinology|February 21, 2004
Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetesLing Fu, Linu M John, Sean H Adams, et al.
The Journal of Clinical Investigation|April 22, 2009
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in miceJing Qing, Xiangnan Du, Yongmei Chen, et al.
Blood|March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphomaAndrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Genes & Development|May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthAdam S Adler, Mark L McCleland, Sharon Yee, et al.
Cancer Cell|October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodiesGabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Pageof 5